Home » Webinars » TIF ITD2020 Webinar: The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia

TIF ITD2020 Webinar: The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia

 

 

9 patients with thalassaemia, members of TIF’s Patient Advocacy Group for Thalassaemia and Sickle Cell Disease (T-PAG), are discussing with the Thalassaemia International Federation the accessibility and affordability of the new and innovative Therapies for the disease, as well as the COVID-19 pandemic challenges in their respective countries.

With the participation of: Mr Seymour Baghbanli, Azerbaijan Mr Riyad Elbard, Canada Mr Ali Sattarpour, France Mr Kostas Tsurlis, Germany Ms Anubha Taneja Mukherjee, India Ms Caecilia Maria Natasha, Indonesia Ms Fazalena Sarawak, Malaysia Mr Issa Ali, Trinidad & Tobago Mr George Constantinou, UK and Dr Androulla Eleftheriou, Executive Director & Dr Michael Angastiniotis, Medical Advisor, on behalf of TIF.